S.E. Khoroshilov
Unresolver problem of calcium in phosphate-binding therapy of bone-mineral metabolism dis-turbances in patients with chronic kidney disease on program hemodialysis
|
№1 / 2014
|
N.V. Voronina, T.B. Agievich
Bone mineral density, bone and phosphate-calcium metabolism parameters in patients with oxalate nephropathy in early stages of chronic kidney disease
|
№1 / 2014
|
N.А. Yarkova, N.N. Borovkov, Е.N. Solov’ianova, L.V. Filina
Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region
|
№1 / 2014
|
S.S. Nagaitseva, M.Yu. Shvetsov, A.N Gerasimov, Yu.D Shalyagin, E.S. Ivanova, E.M. Shilov
Use of survey in chronic kidney disease stratification
|
№1 / 2014
|
M. Tonelli, M. Riella
Chronic kidney disease and the aging population
|
№1 / 2014
|
L.Yu. Milovanova (1), A.A. Plotnikova (1), Yu.S. Milovanov (1), I.A. Dobrosmyslov (1), V.A. Anashkin (2), E.I. Il'inih (3), T.A. Yagupova (4)
Early treatment with phosphate-binders and active metabolites of vitamin D in prevention of secondary hyperparathyreoidism in patients with chronic kidney disease on program hemodialysis
|
№6 / 2013
|
N.I. Solomakhina, I.M. Kutyrina, T.E. Rudenko, M.P. Vaslyeva
Pulmonary hypertension as a sign of heart involvement in chronic kidney disease progression
|
№6 / 2013
|
M.Yu. Krupnova, M.V. Bondarenko, V.V. Marasaev
Chronic kidney disease: risk factors for development and progression
|
№5 / 2013
|
N.A. Mikhailova
Phosphate-binder therapy: economical aspects
|
№5 / 2013
|
A.P. Rebrov, A.L. Kuklina
Renal dysfunction in patients with arterial hypertension in presense and absense of comorbid conditions
|
№5 / 2013
|
A.R. Eraliev, D.M. Demeubaeva, A.E. Naushabaeva, K.A. Kabulbaev, G.N. Chingaeva, B.A. Abeouva, S.M. Dosym, A.B. Kanatbaeva
Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases
|
№4 / 2013
|
N.A. Mikhailova
Magnesium-containing phosphate-binders: new therapeutic opportunities in chronic kidney disease
|
№4 / 2013
|